NCT05935748 — ccRCC trial site landscape

Public-registry site landscape for NCT05935748, a ccRCC study sponsored by NiKang Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05935748 (registry record)
Sponsor	NiKang Therapeutics, Inc.
Condition(s)	ccRCC; Clear Cell Renal Cell Carcinoma; Kidney Cancer; Kidney Neoplasms
Phase	PHASE2
Listed sites	8
Site countries	United States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05935748 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.